India Generic Injectables Market Share, Size, Growth, Opportunity and Forecast 2021-2026

*As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

India Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

India generic injectables market is currently witnessing robust growth. Generic injectables refer to alternative drugs that are bio-equivalent of their branded counterparts in terms of active ingredients, strength, quality, effectiveness, intended use, and dosage. They are used to treat various life-threatening and chronic diseases, such as cancer, diabetes, rheumatoid arthritis, cardiovascular ailments, and respiratory infections. As compared to innovator drugs, generic injectables offer maximized patient compliance, reduced frequency of drug delivery, limited price erosion, and higher profitability for manufacturers.

The increasing prevalence of chronic diseases in India, due to the rising pollution levels and unhealthy lifestyle of the population are the major factors driving the generic injectables market growth. This, in turn, has led to a rise in the expenditure on innovation in generic injectables for effective drug administration and faster recovery of patients. Additionally, an expansion in the life science industry and rapid technological advancements in drug delivery systems, such as the development of self-injection devices, are contributing to the market growth. Moreover, rising economic development in India has resulted in improved healthcare facilities, which is acting as another growth-inducing factor. Apart from this, the increasing shortage of branded medicines and expiry of patents of branded items, are further creating a positive outlook for the market in the country. On account of these factors, the market is expected to continue its robust growth in the forecast period (2021-2026).

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the India generic injectables market report, along with forecasts for growth at the region level from 2021-2026. Our report has categorized the market based on region, therapeutic area, container and distribution channel.

Breakup by Therapeutic Area:

Oncology
Anaesthesia
Anti-infectives
Parenteral Nutrition
Cardiovascular

Breakup by Container:

Vials
Ampoules
Premix
Prefilled Syringes

Breakup by Distribution Channel:

Hospitals
Retail Pharmacy

Breakup by Region:

North India
West and Central India
South India
East India

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Report Coverages:

Report Features	Details
Base Year of the Analysis	2020
Historical Period	2015-2020
Forecast Period	2021-2026
Units	US$ Million
Segment Coverage	Therapeutic Area, Container, Distribution Channel, Region
Region Covered	North India, West and Central India, South India, East India
Customization Scope	10% Free Customization
Report Price and Purchase Option	Single User License: US$ 2499 Five User License: US$ 2999 Corporate License: US$ 3499
Post-Sale Analyst Support	10-12 Weeks
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report:

How has the India generic injectables market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the India generic injectables market?
What are the key regional markets?
What is the breakup of the market based on the therapeutic area?
What is the breakup of the market based on the container?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the India generic injectables market and who are the key players?
What is the degree of competition in the industry?